Philip Morris International's ZYN Production in Pakistan Supports Harm Reduction.

Feb.27
Philip Morris International's ZYN Production in Pakistan Supports Harm Reduction.
Philip Morris International begins local production of ZYN nicotine pouches in Pakistan, expanding tobacco harm reduction efforts.

Key points:


Philip Morris International (PMI) Pakistan has begun local production of ZYN nicotine pouches to support harm reduction in tobacco use.


The production process is divided into stages and is planned to be fully conducted in Pakistan in the future.


According to a report by Brecorder on February 27th, Philip Morris International (PMI) Pakistan's subsidiary (PMPKL) has started production of ZYN nicotine pouches at its factory in Sahiwal.


The first stage of localized production involves packaging imported raw materials to produce finished goods. The second stage will expand to encompass the full manufacturing process of nicotine pouches locally.


The localization production of ZYN in Pakistan is an important move following the authorization of ZYN nicotine pouches by the US FDA for sale in the US market, according to Nicholas Ricketts, CEO of Global Commercial Oral Products.


The authorization by the FDA in the United States firmly validates our commitment to harm reduction in tobacco. This regulatory advancement sets an important precedent that could influence global policies, leading to a significant reduction in smoking rates and actively promoting public health.


Ali Takesh, General Manager of PMPKL, emphasized the importance of providing better alternative products in Pakistan.


Providing adult smokers with less harmful alternatives is the core goal of PMPKL, which aligns with the global vision of Philip Morris International (PMI) to become a smoke-free company by 2030.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.